Seven Eight Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,793
| Closed | -$1.62M | – | 782 |
|
|
2021
Q2 | $1.62M | Sell |
8,793
-20,020
| -69% | -$3.68M | 0.23% | 139 |
|
|
2021
Q1 | $4.5M | Hold |
28,813
| – | – | 1.03% | 2 |
|
|
2020
Q4 | $4.5M | Buy |
+28,813
| New | +$4.5M | 1.02% | 2 |
|
|
2020
Q3 | – | Sell |
-2,213
| Closed | -$248K | – | 682 |
|
|
2020
Q2 | $248K | Sell |
2,213
-19,887
| -90% | -$2.23M | 0.18% | 227 |
|
|
2020
Q1 | $1.98M | Buy |
22,100
+7,093
| +47% | +$637K | 0.51% | 49 |
|
|
2019
Q4 | $1.62M | Sell |
15,007
-65,297
| -81% | -$7.06M | 0.09% | 349 |
|
|
2019
Q3 | $7.87M | Buy |
80,304
+20,602
| +35% | +$2.02M | 0.42% | 60 |
|
|
2019
Q2 | $7.82M | Buy |
+59,702
| New | +$7.82M | 0.41% | 65 |
|
|
2019
Q1 | – | Sell |
-126,402
| Closed | -$12.3M | – | 773 |
|
|
2018
Q4 | $12.3M | Buy |
126,402
+119,300
| +1,680% | +$11.6M | 0.69% | 32 |
|
|
2018
Q3 | $987K | Buy |
+7,102
| New | +$987K | 0.06% | 361 |
|
|
2018
Q2 | – | Sell |
-37,752
| Closed | -$4.21M | – | 620 |
|
|
2018
Q1 | $4.21M | Buy |
37,752
+15,600
| +70% | +$1.74M | 0.35% | 115 |
|
|
2017
Q4 | $2.65M | Buy |
+22,152
| New | +$2.65M | 0.27% | 131 |
|
|
2017
Q3 | – | Sell |
-452
| Closed | -$55K | – | 668 |
|
|
2017
Q2 | $55K | Sell |
452
-1,057
| -70% | -$129K | 0.01% | 479 |
|
|
2017
Q1 | $183K | Buy |
+1,509
| New | +$183K | 0.04% | 369 |
|
|
2016
Q3 | – | Sell |
-10,903
| Closed | -$1.27M | – | 601 |
|
|
2016
Q2 | $1.27M | Buy |
+10,903
| New | +$1.27M | 0.44% | 66 |
|
|
2015
Q2 | – | Sell |
-3,000
| Closed | -$520K | – | 707 |
|
|
2015
Q1 | $520K | Buy |
+3,000
| New | +$520K | 0.87% | 17 |
|